Eden Health Expands Personalized Care Platform Through Acquisition of Contigo Compounding

Custom medications, controlled supply chain, and innovative form factors now part of Eden's integrated health platform

DENVER, Aug. 19, 2025 /PRNewswire/ -- Eden Health, the health platform that connects members with independent, licensed providers for personalized health care, today announced its acquisition of Contigo Compounding, a licensed 503A compounding pharmacy specializing in sterile and non-sterile custom medications.

This acquisition cements Eden's investment in the future of personalized medicine by integrating compounding capabilities in-house, allowing for precision dosing, innovative delivery formats, and responsive care coordination between providers and pharmacists.

"Our vision has always been simple: one care team, end-to-end," said Josh Khan, Co-Founder and President of Eden Health. "We're also looking further ahead. We see this as a major step toward building Healthcare 3.0 a system where advanced personalization, seamless technology, and a controlled supply chain work together so every patient's care is precise, proactive, and uninterrupted. By bringing Contigo into the Eden ecosystem, we're eliminating delays, improving adherence, and giving every member a tailored, responsive treatment journey, from their first consult to their next refill."

Contigo's state-of-the-art facility, compliant with USP <797> and <800> guidelines, will allow Eden to handle all medication preparation internally, allowing for fully personalized treatments and real-time coordination with your care team, with batch sterility testing, real-time inventory tracking, and free next-day shipping.

"Shortages and pricing tiers shouldn't get in the way of care," said Adam McBride, CEO of Eden Health. "With Contigo, we control the supply chain, so we can guarantee flat, transparent pricing and uninterrupted access, even when retail pharmacies can't."

This move enables Eden to expand its precision-medicine offerings, with formulations that reflect the real needs of real people. That includes micro-titration doses, allergy-friendly ingredients, and alternate delivery formats like troches or topical creams, helping members stay consistent without compromising comfort or safety.

"Our pharmacy has always specialized in making medications that work for real-world bodies," said Christopher Smith, PharmD, Founder of Contigo Compounding. "Now, as part of Eden, those customized therapies are integrated directly with the care team, so decisions happen faster, and outcomes improve."

What this may mean for Eden members:

• Faster adjustments to medications, because providers and pharmacists now operate on the same platform
• Flat, transparent pricing, with no surprise markups or insurance roadblocks
• Tailored formulations, to support tolerability, adherence, and better outcomes

The integration of Contigo marks a major milestone in Eden's mission to deliver a fully coordinated, closed-loop care model. Medications are filled and shipped next-day directly from Eden's own pharmacy, ensuring members get exactly what they need, without interruption or third-party bottlenecks.

As part of this expansion, Eden will also open Contigo's sterile hazardous lab capacity to align local clinics and third-party telehealth partners, particularly in states where demand is underserved. This move ensures Contigo's advanced compounding infrastructure is fully utilized while maintaining Eden's high standards for product consistency and operational simplicity.

About Eden

Eden is a health platform built to extend health span through connecting individuals with  personalised, physician-guided programs that may combine personalised medications, lifestyle coaching and community support through independent, licensed physicians. Eden connects members to licensed providers and pharmacists through a single integrated ecosystem.

SOURCE Eden Health